FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.8.3  |  FHIR Version n/a  User: [n/a]

116347002: Moxifloxacin hydrochloride (substance)


Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
177273019 Moxifloxacin hydrochloride en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
677570010 Moxifloxacin hydrochloride (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
3226171000005112 moxifloxacinhydrochlorid da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Moxifloxacin hydrochloride Is a quinolonantibiotikum false Inferred relationship Some
Moxifloxacin hydrochloride Is a Quinolone antibacterial false Inferred relationship Some
Moxifloxacin hydrochloride Is a Moxifloxacin (substance) false Inferred relationship Some
Moxifloxacin hydrochloride This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Moxifloxacin (substance) true Inferred relationship Some
Moxifloxacin hydrochloride This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Antibacterial (disposition) true Inferred relationship Some
Moxifloxacin hydrochloride Is a Fluoroquinolone (substance) true Inferred relationship Some

Inbound Relationships Type Active Source Characteristic Refinability Group
Moxifloxacin hydrochloride 400mg tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Moxifloxacin hydrochloride Inferred relationship Some
moxifloxacinhydrochlorid 0,5 % opløsning til oftalmisk anvendelse The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Moxifloxacin hydrochloride Inferred relationship Some
Moxifloxacin hydrochloride The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Moxifloxacin hydrochloride Inferred relationship Some
Product containing moxifloxacin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Moxifloxacin hydrochloride Inferred relationship Some
moxifloxacinhydrochlorid 1,6 mg/ml infusionsvæske, opløsning, pose a 250 ml The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Moxifloxacin hydrochloride Inferred relationship Some
Product containing precisely moxifloxacin (as moxifloxacin hydrochloride) 400 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Moxifloxacin hydrochloride Inferred relationship Some
Moxifloxacin-containing product in oral dose form The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Moxifloxacin hydrochloride Inferred relationship Some
moxifloxacin til oftalmisk anvendelse The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Moxifloxacin hydrochloride Inferred relationship Some
Product containing moxifloxacin in parenteral dose form (medicinal product form) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Moxifloxacin hydrochloride Inferred relationship Some
Product containing precisely moxifloxacin (as moxifloxacin hydrochloride) 400 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Moxifloxacin hydrochloride Inferred relationship Some 1
Product containing precisely moxifloxacin (as moxifloxacin hydrochloride) 400 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Moxifloxacin hydrochloride Inferred relationship Some 1
Product containing precisely moxifloxacin (as moxifloxacin hydrochloride) 400 milligram/250 milliliter conventional release solution for infusion bag The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Moxifloxacin hydrochloride Inferred relationship Some 1
Moxifloxacin (as moxifloxacin hydrochloride) 1.6 mg/mL solution for infusion The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Moxifloxacin hydrochloride Inferred relationship Some 1
Product containing precisely moxifloxacin (as moxifloxacin hydrochloride) 5 milligram/1 milliliter conventional release eye solution (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Moxifloxacin hydrochloride Inferred relationship Some 1
Moxifloxacin (as moxifloxacin hydrochloride) 1.6 mg/mL solution for injection The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Moxifloxacin hydrochloride Inferred relationship Some 1
Product containing precisely moxifloxacin (as moxifloxacin hydrochloride) 1.6 milligram/1 milliliter conventional release solution for infusion and/or injection (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Moxifloxacin hydrochloride Inferred relationship Some 1

This concept is not in any reference sets

Back to Start